Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group.
Guilhot F, Guerci A, Fiere D, Harousseau JL, Maloisel F, Bouabdallah R, Guyotat D, Rochant H, Najman A, Nicolini F, Colombat P, Abgrall JF, Ifrah N, Brière J, Bauters F, Navarro M, Morice P, Bordessoule D, Vilque JP, Desablens B, Tertian G, Blanc M, Chastang C, Tanzer J. Guilhot F, et al. Among authors: ifrah n. Bone Marrow Transplant. 1996 May;17 Suppl 3:S29-31. Bone Marrow Transplant. 1996. PMID: 8769697 Clinical Trial. No abstract available.
A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results.
Guilhot F, Lamagnère JP, Harousseau JL, Tilly H, Casassus P, Ifrah N, Rochant H, Bauters F, Dine G, Tanzer J. Guilhot F, et al. Among authors: ifrah n. Eur J Cancer. 1991;27 Suppl 4:S26. doi: 10.1016/0277-5379(91)90561-q. Eur J Cancer. 1991. PMID: 1799470 Clinical Trial. No abstract available.
A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic results.
Guilhot F, Abgrall JF, Harousseau JL, Bauters F, Brice P, Dine G, Tilly H, Ifrah N, Cassasus P, Rochant H, et al. Guilhot F, et al. Among authors: ifrah n. Leuk Lymphoma. 1993;11 Suppl 1:181-3. doi: 10.3109/10428199309047883. Leuk Lymphoma. 1993. PMID: 8251893 Clinical Trial.
Intensive therapy for high grade multiple myeloma (MM).
Harousseau JL, Milpied N, Jouet JP, Colombat P, Guilhot F, Laporte JP, Ifrah N, Gandhour C, Casassus P. Harousseau JL, et al. Among authors: ifrah n. Bone Marrow Transplant. 1991;7 Suppl 2:28. Bone Marrow Transplant. 1991. PMID: 1878703 No abstract available.
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase.
Maloisel F, Guerci A, Guyotat D, Ifrah N, Michallet M, Reiffers J, Tertain G, Blanc M, Bauduer F, Brière J, Abgrall JF, Pegourie-Bandelier B, Solary E, Cambier N, Coso D, Vilque JP, Delain M, Harousseau JL, Rousselot P, Belhadj K, Morice P, Attal J, Chabin M, Chastang C, Guilhot J, Guilhot F; France Intergroupe des Leucémies Myéloïdes Chroniques. Maloisel F, et al. Among authors: ifrah n. Leukemia. 2002 Apr;16(4):573-80. doi: 10.1038/sj.leu.2402433. Leukemia. 2002. PMID: 11960335 Clinical Trial.
Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy.
Vigouroux S, Milpied N, Andrieu JM, Colonna P, Ifrah N, Colombat P, Desablens B, Abgrall JF, Casassus P, Guilhot F, Briere J, Le Mevel A, Moreau P, Mechinaud F, Mahe B, Morineau N, Vigier M, Rapp MJ, Harousseau JL. Vigouroux S, et al. Among authors: ifrah n. Bone Marrow Transplant. 2002 May;29(10):833-42. doi: 10.1038/sj.bmt.1703547. Bone Marrow Transplant. 2002. PMID: 12058233
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study.
Solary E, Witz B, Caillot D, Moreau P, Desablens B, Cahn JY, Sadoun A, Pignon B, Berthou C, Maloisel F, Guyotat D, Casassus P, Ifrah N, Lamy Y, Audhuy B, Colombat P, Harousseau JL. Solary E, et al. Among authors: ifrah n. Blood. 1996 Aug 15;88(4):1198-205. Blood. 1996. PMID: 8695837 Free article. Clinical Trial.
Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM).
Jourdan E, Maraninchi D, Reiffers J, Gluckman E, Rio B, Jouet JP, Michallet M, Molina L, Archimbaud E, Harousseau JL, Ifrah N, Attal M, Guilhot F, Kuentz M, Guyotat D, Pico JL, Dauriac C, Legros M, Dreyfus F, Bordigoni P, Leblond V, Gratecos N, Varet B, Auzanneau C, Blaise D, et al. Jourdan E, et al. Among authors: ifrah n. Bone Marrow Transplant. 1997 May;19(9):875-81. doi: 10.1038/sj.bmt.1700761. Bone Marrow Transplant. 1997. PMID: 9156260
305 results